CIK: 0001766721 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 13, 2025
Total Value ($000): $359,672 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma Inc. (BBIO) | 6,068,125 | $262,022 | 72.9% | $40.43 | -10.0% | COM | 10806X102 |
| — | Verona Pharma plc (VRNA) | 615,352 | $58,200 | 16.2% | $7.38 | — | SPONSORED ADS | 925050106 |
| SNDX | Syndax Pharmaceuticals, Inc. (SNDX) | 1,316,806 | $12,325 | 3.4% | $10.41 | +5.7% | COM | 87164F105 |
| GLUE | Monte Rosa Therapeutics Inc (GLUE) | 1,472,331 | $6,640 | 1.8% | $20.37 | -78.1% | COM | 61225M102 |
| BCAX | Bicara Therapeutics Inc. (BCAX) | 568,919 | $5,285 | 1.5% | $25.50 | -53.3% | COM | 055477103 |
| NUVB | Nuvation Bio Inc. (NUVB) | 2,541,009 | $4,955 | 1.4% | $11.18 | -81.4% | COM CL A | 67080N101 |
| BMEA | Biomea Fusion Inc (BMEA) | 2,048,757 | $3,688 | 1.0% | $8.06 | -76.1% | COM | 09077A106 |
| CMPS | Compass Pathways Plc (CMPS) | 1,198,418 | $3,356 | 0.9% | $6.51 | — | SPONSORED ADS | 20451W101 |
| — | Elevation Oncology Inc (ELEV) | 2,834,910 | $1,041 | 0.3% | $13.57 | — | COM | 28623U101 |
| CALC | CalciMedica, Inc. (CALC) | 521,114 | $834 | 0.2% | $4.55 | -62.3% | COM NEW | 38942Q202 |
| ACRS | Aclaris Therapeutics Inc (ACRS) | 434,455 | $617 | 0.2% | $10.31 | -86.9% | COM | 00461U105 |
| MRKR | Marker Therapeutics, Inc. (MRKR) | 325,370 | $498 | 0.1% | $1.80 | -28.7% | COM NEW | 57055L206 |
| OKUR | OnKure Therapeutics, Inc. (OKUR) | 88,607 | $212 | 0.1% | $15.14 | -82.7% | COM CL A | 68277Q105 |